Mesenteric lipodystrophy (Q90951): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Mesenterite esclerosante (retrátil), paniculite mesentérica e lipodistrofia mesentérica são lesões incomuns caracterizadas por uma expansão semelhante a tumor do mesentério, composta por graus variáveis de fibrose, inflamação crônica e necrose gordurosa. A lipodistrofia mesentérica é caracterizada por predomínio de necrose gordurosa com pouca ou nenhuma fibrose ou inflamação crônica no mesentério. | |||
| description / en | description / en | ||
Sclerosing (retractile) mesenteritis, mesenteric panniculitis, and mesenteric lipodystrophy are unusual lesions characterized by a tumorlike expansion of the mesentery composed of variable degrees of fibrosis, chronic inflammation, and fat necrosis. Mesenteric lipodystrophy is characterized with a predominance of fat necrosis with little or no fibrosis or inflammation in mesentery. | |||
Revision as of 17:56, 15 August 2026
Sclerosing (retractile) mesenteritis, mesenteric panniculitis, and mesenteric lipodystrophy are unusual lesions characterized by a tumorlike expansion of the mesentery composed of variable degrees of fibrosis, chronic inflammation, and fat necrosis. Mesenteric lipodystrophy is characterized with a predominance of fat necrosis with little or no fibrosis or inflammation in mesentery.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1564440835 |
||
| English | Mesenteric lipodystrophy |
Sclerosing (retractile) mesenteritis, mesenteric panniculitis, and mesenteric lipodystrophy are unusual lesions characterized by a tumorlike expansion of the mesentery composed of variable degrees of fibrosis, chronic inflammation, and fat necrosis. Mesenteric lipodystrophy is characterized with a predominance of fat necrosis with little or no fibrosis or inflammation in mesentery. |
